Table 2.
2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
No diabetes | |||||||||||
N | 1447 | 1431 | 1458 | 1462 | 1365 | 1332 | 1329 | 1315 | 1177 | 1120 | 13436 |
Incidence* | 12,28 | 12.15 | 11.94 | 11.56 | 10.8 | 10.26 | 9.98 | 9.87 | 8.6 | 8.18 | 10.49 |
Age, mean (SD) | 70.03 (7.62) | 69.91 (7.51) | 70.02 (7.67) | 69.83 (7.72) | 69.92 (7.7) | 70.04 (7.95) | 69.71 (8) | 69.52 (8.28) | 69.54 (8.03) | 69.97 (8.16) | 69.85 (7.85) |
Male, n (%)* | 1377 (95.16) | 1379 (96.37) | 1407 (96.5) | 1401 (95.83) | 1292 (94.65) | 1268 (95.2) | 1240 (93.3) | 1247 (94.83) | 1094 (92.95) | 1057 (94.38) | 12762 (94.98) |
CCI 0–1, n (%)* | 826 (57.08) | 773 (54.02) | 832 (57.06) | 867 (59.3) | 811 (59.41) | 761 (57.13) | 770 (57.94) | 762 (57.95) | 721 (61.26) | 704 (62.86) | 7827 (58.25) |
CCI 2, n (%) | 448 (30.96) | 485 (33.89) | 446 (30.59) | 457 (31.26) | 408 (29.89) | 430 (32.28) | 426 (32.05) | 428 (32.55) | 343 (29.14) | 311 (27.77) | 4182 (31.13) |
CCI ≥3, n (%) | 173 (11.96) | 173 (12.09) | 180 (12.35) | 138 (9.44) | 146 (10.7) | 141 (10.59) | 133 (10.01) | 125 (9.51) | 113 (9.6) | 105 (9.38) | 1427 (10.62) |
Smoking* | 588 (40.64) | 600 (41.93) | 607 (41.63) | 564 (38.58) | 537 (39.34) | 523 (39.26) | 548 (41.23) | 575 (43.73) | 527 (44.77) | 475 (42.41) | 5544 (41.26) |
LOSH, mean (SD)* | 15 (15) | 14 (15) | 13 (15) | 12 (13) | 12 (14) | 12 (14) | 12 (13) | 11 (12) | 10 (12) | 10 (11) | 12 (14) |
IHM, n (%) | 272 (18.8) | 259 (18.1) | 231 (15.84) | 236 (16.14) | 241 (17.66) | 223 (16.74) | 226 (17.01) | 219 (16.65) | 205 (17.42) | 183 (16.34) | 2295 (17.08) |
Diabetes | |||||||||||
N | 160 | 205 | 180 | 196 | 208 | 203 | 212 | 188 | 234 | 216 | 2002 |
Incidence* | 6.7 | 8.59 | 7.23 | 7.57 | 8.03 | 7.19 | 7.16 | 6.35 | 6.95 | 6.41 | 7.17 |
Age, mean (SD) | 69.87 (6.57) | 70.32 (7.27) | 70.33 (6.97) | 69.72 (7.7) | 69.32 (7.55) | 69.2 (7.41) | 69.36 (7.95) | 70.01 (7.4) | 70.02 (8.08) | 69.31 (8.11) | 69.73 (7.55) |
Male, n (%) | 157 (98.13) | 200 (97.56) | 173 (96.11) | 189 (96.43) | 200 (96.15) | 194 (95.57) | 206 (97.17) | 180 (95.74) | 221 (94.44) | 207 (95.83) | 1927 (96.25) |
CCI 0–1, n (%) | 80 (50) | 100 (48.78) | 103 (57.22) | 111 (56.63) | 116 (55.77) | 111 (54.68) | 119 (56.13) | 121 (64.36) | 135 (57.69) | 120 (55.56) | 1116 (55.74) |
CCI 2, n (%) | 52 (32.5) | 73 (35.61) | 56 (31.11) | 64 (32.65) | 69 (33.17) | 66 (32.51) | 74 (34.91) | 53 (28.19) | 81 (34.62) | 74 (34.26) | 662 (33.07) |
CCI ≥3, n (%) | 28 (17.5) | 32 (15.61) | 21 (11.6) | 21 (10.71) | 23 (11.06) | 26 (12.81) | 19 (8.96) | 14 (7.45) | 18 (7.69) | 22 (10.19) | 224 (11.19) |
Smoking | 73 (45.63) | 89 (43.41) | 82 (45.56) | 76 (38.78) | 78 (37.5) | 80 (39.41) | 103 (48.58) | 85 (45.21) | 93 (39.74) | 103 (47.69) | 862 (43.06) |
LOSH, mean (SD)* | 16 (18.5) | 13 (16) | 12 (14) | 13 (14) | 12 (13) | 11 (10) | 11 (11.5) | 11 (10) | 9 (10) | 9 (7) | 11 (12) |
IHM, n (%) | 19 (11.88) | 28 (13.66) | 27 (15) | 36 (18.37) | 24 (11.54) | 26 (12.81) | 21 (9.91) | 21 (11.17) | 37 (15.81) | 27 (12.5) | 266 (13.29) |
N: Number of procedures; Incidence: per 100,000 inhabitants; LOHS: length of stay; IHM: In-hospital mortality; CCI (Charlson Comorbidity Index): Comorbidities included in the Charlson comorbidity index, except diabetes.*P < 0.05 (ANOVA or Kruskal-Wallis analysis) or (χ2 linear trend analysis).